Effect of pantoprazole on I-R -induced myocardial injury in diabetic rats targeting inflammatory cytokine release and oxidative stress

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 416

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-24-5_007

تاریخ نمایه سازی: 18 اردیبهشت 1400

چکیده مقاله:

Objective(s): To evaluate the pleiotropic potential and underlying mechanism of pantoprazole (PPZ) (common Proton Pump Inhibitors, PPIs) in type ۲ diabetes mellitus (T۲DM) -associated ischemia/reperfusion (I-R)-induced myocardial infarction which is still uncharted. Whereas some other PPIs have demonstrated their anti-diabetic, antioxidant, and anti-inflammatory potential. Materials and Methods: We evaluated the potential of coinciding treatment of PPZ (۴ mg/kg/po/day for ۸ weeks) in Wistar albino rats against STZ (۵۰ mg/kg/IP) induced T۲DM model and I-R provoked cardiac infarction model in diabetic and non-diabetic condition. Results: PPZ significantly inhibited the perturbed deviations in blood glucose concentration, HbA۱c, C-peptide, plasma insulin, and ameliorated the lipid profile (dyslipidemia). PPZ protected myocardial tissue against lipid peroxidation by restoring the levels of serum TBARS and reduced NBT. The significant protective effects of PPZ were evident by ameliorating CKMB, LDH, cTnI, and myocardial oxidative stress in PPZ treated animals. Additionally, PPZ prominently reduced various proinflammatory cytokines release including TGF-β۱, TNF-α, and IL-۶. PPZ upsurges the bioavailability of nitrite/nitrate concentration which may pacify the impact of myocardial infarction in diabetic I-R injury. Conclusion: The consequences indicate that PPZ possesses a potent protective effect against diabetic I-R-induced myocardial infarction via suppressing oxidative stress, inflammation, and dyslipidemia-associated tissue damage.

نویسندگان

Gaurav Taneja

Department of Pharmacology, Amity Institute of Pharmacy, Amity University, Uttar Pradesh-۲۰۱۳۰۳, India

Arun Sharma

Cardiovascular Division, Department of Pharmacology, Amity University Haryana, Gurugram-۱۲۲۴۱۳, India

Deepa Khanna

Rajendra Institute of Technology and Sciences (RITS), Sirsa, Haryana, India

Satyendra Rajput

Department of Pharmacology, Amity Institute of Pharmacy, Amity University, Uttar Pradesh-۲۰۱۳۰۳, India

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • 1. Demographic and geographic outline. [cited 2021 Jan 1]. Available ...
  • 3. Sharma G, Sahu M, Kumar A, Sharma AK, Aeri ...
  • 4. Yu XY, Chen HM, Liang JL, Lin QX, Tan ...
  • 5. Ghebre Y and Raghu G. Proton pump inhibitors in ...
  • 6. Naseri E and Yenisehirli A. Proton pump inhibitors omeprazole ...
  • 7. Lin H, Li Y, Zhu H, Wang Q, Chen ...
  • 8. Yenisehirli A and Onur R. Positive inotropic and negative ...
  • 9. Patlolla JMR, Zhang Y, Li Q, Steele VE, and ...
  • 10. Yates TA, Tomlinson LA, Bhaskaran K, Langan S, Thomas ...
  • 11. Dias LM. Pantoprazole: A proton pump inhibitor. Clin Drug ...
  • 12. Tabeefar H, Beigmohammadi MT, Javadi MR, Abdollahi M, Mahmoodpoor ...
  • 13. Koh JS, Joo MK, Park JJ, Yoo HS, Choi ...
  • 14. Yan X-X, Zheng A-D, Zhang Z-E, Pan G-C, and ...
  • 15. Does pantoprazole protect against reperfusion injury following myocardial ischemia ...
  • 17. Sharma AK, Kumar A, Taneja G, Nagaich U, Deep ...
  • 18. Casciaro M, Navarra M, Inferrera G, Liotta M, Gangemi ...
  • 19. Villegas K, Meier JL, Long M, Lopez J, and ...
  • 20. Lin H-C, Hsiao Y-T, Lin H-L, Uang Y-S, Cheng ...
  • 21. Sherwani SI, Khan HA, Ekhzaimy A, Masood A, and ...
  • 22. Sharma G, Ashhar MU, Aeri V, and Katare DP. ...
  • 23. Sharma AK, Kumar A, Taneja G, Nagaich U, Deep ...
  • 24. Sharma AK, Taneja G, Khanna D, and Rajput SK. ...
  • 25. Wang Y, Song X, Yue X, Su H, Gu ...
  • 26. Xia M, Liu L, Qiu R, Li M, Huang ...
  • 27. Kumar S, Malhotra R, and Kumar D. Euphorbia hirta : ...
  • 28. Subramanian SP, Bhuvaneshwari S, and Prasath GS. Antidiabetic and ...
  • 29. Sharma AK, Khanna D, and Balakumar P. Low-dose dipyridamole ...
  • 30. Beysel S, Unsal IO, Kizilgul M, Caliskan M, Ucan ...
  • نمایش کامل مراجع